479 results
What did 2022 tell us so far in interventions? Essential publications from the EuroIntervention Journal and the European Heart Journal
19 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session lists the best EIJ and EHJ publications in terms of coronary interventions, intravascular imaging and physiology, interventions for mitral and tricuspid valve disease, and interventions for aortic valve disease.
EuroPCR 2022 Hotlines / Late-Breaking Trials in mitral and tricuspid: MITRA-TUNE, MitraBridge, TriCLASP, CLASP TR, and more!
19 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in mitral and tricuspid! MitraClip in atrial functional mitral regurgitation, two-year outcomes of MitraClip as a bridge to heart transplantation, TriCLASP post-market study, CLASP TR study one-year results, Cardioband TR early feasibility study, and initial 30-day results from...
TriClip therapy: here now, here to stay
19 May 2022 – From EuroPCR 2022
Discover how tricuspid clip dedicated therapy allows treating a broad range of anatomies through real-life cases. Also, learn about its real-world outcomes and the performance in different tricuspid regurgitation patient profiles.
A patient-focused transcatheter portfolio of options to treat tricuspid regurgitation
19 May 2022 – From EuroPCR 2022
In this session from EuroPCR 2022, the speakers introduce different options available for treating tricuspid regurgitation. They discuss the anatomical considerations that define suitable candidates and review different transcatheter options and their key differentiators.
PCR Innovators Day - Innovations for valve treatment: new devices, new tools, new procedures
19 May 2022 – From EuroPCR 2022
Valvular heart disease is probably one of the most innovative areas in cardiovascular medicine at large: tremendous progress has been made both in terms of quality of life and mortality. Technology continues to evolve, as there are still many gaps to be filled, and it is...
Bright future ahead for tricuspid regurgitation management
19 May 2022 – From EuroPCR 2022
In this conversation between Philipp Lurz and Felix Kreidel, recorded for EuroPCR 2022, learn more about the bRIGHT study and the latest outcomes released, and further understand TriClip therapy real-world outcomes applicability in daily practice.
View more videos and course resources here!
TricValve - Addressing the unmet need for patients with right heart failure and functional tricuspid regurgitation - Real-life clinical outcomes
18 May 2022 – From EuroPCR 2022
Watch this EuroPCR 2022 session to learn all about the latest treatment option for patients with severe TR, to discover the supporting clinical evidence of TricValve, and to understand how the TricValve Transcatheter Bicaval Valves System can improve patient's quality of life.
A new focus on mitral and tricuspid valve disease
18 May 2022 – From EuroPCR 2022
Find out more about the need for transcatheter replacement in the atrioventricular valves and the Intrepid programme, the potential of transvenous transseptal versus transapical access to the mitral valve, and the future of transvenous tricuspid valve replacement in this EuroPCR 2022 session.
PCR Tricuspid Focus Group update: present and future of tricuspid regurgitation treatment
17 May 2022 – From EuroPCR 2022
Follow the discussions based on the case of an 85-year-old male patient with HTN, mild secondary PAH, DCM, LVEF 45 %, and surgical bioAVR and MVR, presenting with progressive SOB and signs of right HF, severe secondary TR 4/5, and permanent AF, and note the indications of...
Innovations in simulation-based training, procedural planning, monitoring and robotic PCI
17 May 2022 – From EuroPCR 2022
In this session, find out more about telemedicine, mixed reality technology in CTO proctoring, new-human grade simulator for ViV procedure planning, distance proctoring for transseptal TMVR, stent positioning assistance system, and robotic PCI.
